Ionis Pharmaceuticals has retained the Chase Group to assist in their search to secure a Vice President of Finance. Based on growth at this publicly… Continue Reading →
The Chase Group, Inc. is pleased to announce the successful completion of a search for Vice President of Internal and External Communications for Ipsen Biopharmaceuticals,… Continue Reading →
Ipsen US has retained The Chase Group to secure a Vice President of Internal and External Communications to lead all corporate communications initiatives for this… Continue Reading →
The Chase Group is partnered with Eli Lilly in the recruitment of a physician with expertise in GI medical oncology to join their US Medical… Continue Reading →
The Chase Group announces the closing of the VP of Marketing search with Acorda Therapeutics, a world-leading biotechnology company developing therapies to improve neurological function… Continue Reading →
The Chase Group is proud to announce the completion of marketing leadership searches for both the CNS and Oncology business units at Ipsen US. Representing… Continue Reading →
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the… Continue Reading →
Acorda has, once again, engaged The Chase Group to help build their Medical Affairs team. We seek a physician with CNS medical affairs experience. Acorda… Continue Reading →
AbbVie has retained The Chase Group to secure a Director of Global Regulatory Strategy. AbbVie is committed to adding exceptional regulatory professionals to its Global… Continue Reading →
Eisai Pharmaceuticals has partnered with The Chase Group to identify oncology talent for two critical positions within their Clinical Development organization. We are pleased to… Continue Reading →